Current concepts and clinical applications of coronary beta adrenergic receptors;Attuali concetti sulla fisiopatologia dei recettori beta-adrenergici nelle coronarie e sulle sue applicazioni cliniche

Recenti Progressi in Medicina

Volumn 96, Issue 9, 2005, Pages 411-415

  Barbato, Emanuele ^a,b   Wijns, William ^b   De Bruyne, Bernard ^b   Mascia, Giuseppe ^a   Piscione, Federico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDIOVASCULAR CENTER   (Belgium)

Author keywords

Beta adrenergic; Blood flow; Cardiac ischemia; Coronary; Receptor

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR;

CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DISEASE EXACERBATION; EPICARDIUM; HEART MUSCLE ISCHEMIA; HUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC REFLEX;

ADRENERGIC BETA-AGONISTS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; HUMANS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 25144510438     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Berne RM, Rubio R. Coronary circulation. In: Handbook of physiology, sect 2: The cardiovascular system; vol I, edited by SR Geiger. Washington: American Physiological Society 1979; 873-952.
2. Parrat JR. Effects of adrenergic activators and inhibitors on the coronary circulation. In: Szekeres L, ed. Handbook of experimental pharmacology; vol 54/I. Berlin: Springer-Verlag 1980; 735-822
3. Vatner S, Hintze TH, Macho P. Regulation of large coronary arteries by β-adrenergic mechanisms in the conscious dog. Circ Res 1982; 51: 56-66.
4. Winbury MM, Howe BB, Hefner MA. Effects of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. J Pharmacol Exp Ther 1969; 168: 70-95.
5. Ross G, Jorgensen CR. Effects of cardio-selective beta adrenergic blocking agent on the heart and coronary circulation. Cardiovasc Res 1970; 4: 148-53.
6. Adam KR, Boyles S, Scholfield PC. Cardio-selective β adrenoceptor blockade and the coronary circulation. Br J Pharmacol 1970; 40: 534-6.
7. McRaven DR, Mark AL, Abboud FM, et al. Responses of coronary vessels to adrenergic stimuli. J Clin Invest 1971; 50: 773-8.
8. Mark AL, Abboud FM, Schmid PG, et al. Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels. J Clin Invest 1972; 51: 279-87.
9. Gross GJ, Feigl EO. Analysis of coronary vascular beta receptors in situ. Am J Physiol 1975; 228: 1909-13.
10. 2-receptor-mediated dilation of isolated human coronary arterioles. Circulation 2002; 106: 550-5.
11. Ghaleh B, Béa ML, Dubois-Randé JL, et al. Endothelial modulation of beta-adrenergic dilation of large coronary arteries in conscious dogs. Circulation 1995; 92: 2627-35.
12. Barbato E, Bartunek J, Wyffels E, et al. Effects of intravenous dobutamine on coronary vasomotion in humans. J Am Coll Cardiol 2003; 42: 1596-601.
13. Vatner SF, Hintze TH, Macho P. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog. Circ Res 1982; 51: 56-66.
14. Hodgson JM, Cohen MD, Szentpetery S, et al. Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 1989; 79: 797-809.
15. Ferro A, Kaumann AJ, Brown MJ. Beta-adrenoceptor subtypes in human coronary artery: desensitization of beta2-adrenergic vasorelaxation by chronic betai-adrenergic stimulation in vitro. J Cardiovasc Pharmacol 1995; 25:134-41.
16. 2 adrenergic receptor in human atherosclerotic coronary arteries. Circulation 2005; 111: 288-94.
17. Corr L, Burnstock G, Poole-Wilson P. Responses of the rabbit epicardial coronary artery to acetylcholine and adrenoceptor agonists. Cardiovasc Res 1991; 25: 256-62.
18. Frishman WH. β-adrenergic blockers. Med Clin North Am 1988; 72: 37-82.
19. Bordeaux A, Duhaze P, Giudicelli JF. Pharmacological analysis of beta adrenoceptor blockade-induced coronary blood flow redistribution in dogs using 1-penbutol. J Pharmacol Exp Ther 1982; 221: 740-7.
20. Guth BD, Heusch G, Seitelberger R, et al. Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 1987; 60: 738-46.
21. Bordeaux A, Drieu la Rochelle C, Richard V, et al. Opposed responses of large and small coronary arteries to propranolol during exercise in dogs. Am J Physiol 1991; 261: H265-70.
22. Drieu la Rochelle C, Giudicelli JF, Berdeaux A. Differential effects of celiprolol and atenolol on large epicardial coronary arteries in conscious dogs at rest and during exercise. J Cardiovasc Pharmacol 1993; 22: 15-21.
23. Robertson RM, Wood AJJ, Vaughn WK, et al. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 1982; 65: 281-5.
24. Kern MJ, Ganz P, Horowitz JD, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation 1983; 67: 1178-85.
25. Kern MJ, Petru MA, Ferry DR, et al. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease. J Am Coll Cardiol 1985; 5: 1438-50.
26. Gaglione A, Hess OM, Corin WJ, et al. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol 1987; 10: 299-310.
27. Bortone AS, Hess OM, Gaglione A, et al. Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease. Circulation 1990; 81: 1225-35.